Alignment Healthcare, Inc. (ALHC) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. Alignment Healthcare, Inc. operates as a consumer-centric Medicare Advantage platform serving seniors in California, North Carolina, Nevada, Arizona, and Texas. As of the period end, the company reported 284,800 Health Plan Members, representing a 30.9% increase year-over-year. The company operates as a single reportable segment focused on providing healthcare services to seniors.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Total Revenues | $1,235.2 million | $926.9 million | +33.3% |
| Net Income | $11.4 million | ($9.4 million) Loss | Turnaround to Profit |
| Operating Income | $15.5 million | ($5.4 million) Loss | +387.5% |
| Medical Benefits Ratio (MBR) | 88.2% | 88.4% | -0.2% |
| Adjusted EBITDA | $37.9 million | $20.2 million | +87.6% |
| Cash and Cash Equivalents | $705.6 million | $446.2 million | +58.1% |
| Long-Term Debt (Net) | $323.6 million | $323.2 million | Flat |
Liquidity: The company generated $128.7 million in net cash from operating activities, a significant increase from $16.6 million in the prior year. Total cash, cash equivalents, and restricted cash stood at $707.7 million.
Material Changes vs. Prior Period
- Revenue Growth: Earned premiums increased by $308.5 million (33.6%), driven primarily by a 30.9% increase in Health Plan membership and higher CMS benchmark rates.
- Profitability: The company achieved a net income of $11.4 million compared to a net loss of $9.4 million in Q1 2025. Operating income turned positive ($15.5 million) from a loss of $5.4 million.
- Expense Management: Medical expenses rose 32.9% to $1.09 billion, tracking closely with membership growth. Selling, general, and administrative (SG&A) expenses increased 16.7% but decreased as a percentage of revenue from 11.2% to 9.8% due to economies of scale.
- Strategic Shifts: The company discontinued participation in the ACO REACH model as of December 31, 2025, and no longer has capitation arrangements with third-party payors as of January 1, 2026.
Guidance, Outlook, and Risks
Outlook and Commentary: Management attributes the improved financial performance to the scalability of their clinical model, which lowers Medical Benefits Ratios (MBR) for returning members over time. The company plans to continue investing in its AVA technology platform and expanding into new markets. They believe current liquid assets are sufficient to fund operations for at least the next 12 months.
Capital Structure Updates:
- Convertible Notes: $330 million of 4.25% Convertible Senior Notes remain outstanding, maturing in November 2029.
- Credit Facility: On February 26, 2026, the company entered into a new $200 million senior secured revolving credit facility. No amounts were drawn as of March 31, 2026.
Risks and Contingencies:
- Regulatory Audits: The company is undergoing a Risk Adjustment Data Validation (RADV) audit for its California HMO plan regarding payment year 2019. While a Federal District Court vacated a CMS rule regarding extrapolation in September 2025, the company continues to monitor the potential impact of these audits.
- Capital Requirements: The company must maintain compliance with Risk-Based Capital (RBC) and Tangible Net Equity (TNE) requirements in various states.
- Forward-Looking Risks: Risks include the ability to achieve profitability, dependence on CMS reimbursements, cybersecurity threats, and the impact of inflation on labor and unit costs.
Investor Verification Checklist
- Verify the sustainability of the Medical Benefits Ratio (MBR) improvement as the company scales membership, given that new members typically have higher initial MBRs.
- Monitor the outcome of the ongoing RADV audit for the California HMO plan and any potential retrospective payment adjustments.
- Assess the impact of the new $200 million credit facility covenants, specifically the requirement to maintain minimum Consolidated EBITDA levels starting June 30, 2026.
- Review the equity-based compensation expense trends, particularly the new market-based Performance Share Units (PSUs) granted to the CEO, which vest based on stock price hurdles.
- Confirm the company's ability to maintain 4-star or higher CMS ratings, which are critical for financial incentives and member retention.